Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema

Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the ‘DR-Pro-DEX Study’

(2018) Matias Iglicki et al.   ACTA DIABETOLOGICA

OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant

(2018) Dinah Zur et al.   OPHTHALMOLOGY

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES

(2018) Matias Iglicki et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema

(2018) Raj K. Maturi et al.   JAMA Ophthalmology

Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data

(2017) I Chatziralli et al.   EYE

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

(2017) Ursula Schmidt-Erfurth et al.   OPHTHALMOLOGICA

Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome

(2017) Irini Chatziralli et al.   Diabetes Therapy

Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome

(2017) Irini Chatziralli et al.   Diabetes Therapy

Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy

(2016) Rehan M. Hussain et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)

(2016) Samantha Fraser-Bell et al.   OPHTHALMOLOGY

PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA

(2016) Sanket U. Shah et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

An eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy

(2016)   International Journal of Ophthalmology

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets

(2015) Arup Das et al.   OPHTHALMOLOGY

A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY

(2015) Raj K. Maturi et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema

(2014) Mark C. Gillies et al.   OPHTHALMOLOGY

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

(2014) David S. Boyer et al.   OPHTHALMOLOGY

Dexamethasone Intravitreal Implant for Treatment of Patients with Persistent Diabetic Macular Edema

(2013) Marco Dutra Medeiros et al.   OPHTHALMOLOGICA

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY